🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Is #ADHD causally related to #MDD? Study investigating the association between #ADHD and #MDD from 3 different genetically informed designs 🧬 sciencedirect.com/science/articl… Great work by Miguel Garcia-Argibay Isabell Brikell @anita_thapar1 Ditte Demontis Henrik Larsson & many more!

New study suggests small ⚠️ for ♥️ events after starting ADHD med #methylphenidate, but not 20%+ risks as feared. Balancing benefits & possible modest risks still key. More evidence on CV effect size needed - stayed tuned! #ADHD #pharmacoepi #publichealth jamanetwork.com/journals/jaman…

Large Swedish study of over 2 million men finds #finasteride and #dutasteride💊are associated with increased risk of #depression that remains constant over time. No clear long-term link to #dementia. Prescribers should carefully weigh depression risk. jamanetwork.com/journals/jaman…

New study shows parents perceive ADHD symptoms as causing more impairment in their kids compared to past generations. Time to explore why parents' views are changing! #ADHD #MentalHealth acamh.onlinelibrary.wiley.com/doi/full/10.10…

Our systematic review/meta-regression led by Dr Gonzalo Salazar de Pablo in molecularpsychiatry The long road to #precision #medicine in #ADHD. Out of 100 individualised models in #ADHD, only 7% were internally validated and none was implemented in clinical practice. nature.com/articles/s4138…

New study reveals steeper secular trends in BMI for youth with neurodevelopmental disorders. Highlights growing obesity risk & need for targeted prevention. #NDDresearch jamanetwork.com/journals/jaman…

Our paper in The Lancet Psychiatry led by the brilliant Miguel Garcia-Argibay: 53% of individuals with #ADHD in real-world would be ineligible for randomised controlled trials.  Triangulating evidence from RCTs and real-world studies is crucial. thelancet.com/journals/lanps…

New study in The Lancet Psychiatry: Over half of ADHD patients would be ineligible for clinical trials that guide treatment. In adults, it's 74%! These excluded patients show higher risks of hospitalization & other adverse outcomes. thelancet.com/journals/lanps…

Our study in Molecular Psychiatry "provides evidence that in utero exposure to #ADHD medications does not increase the risk of long-term #neurodevelopmental disorders in offspring" nature.com/articles/s4138…

⚠️ ⚠️ Very important paper for #evidence #synthesis researchers ⚠️⚠️ Led by the amazing Corentin Gosling from Université Paris Nanterre Out in Research Synthesis Methods cambridge.org/core/journals/…

New network meta-analysis (102 RCTs) finds short-term use of most #ADHD meds (stimulants & non-stimulants) linked to small increases in BP/pulse (except Guanfacine). #ADHDresearch #CardioSafety #Medication thelancet.com/journals/lanps…